Ejaz Shah, Syed Mujtaba Ali Naqvi, Syed Maaz Tariq, Manpreet Saini, Shi-Ming Tu. "Real-world comparative outcomes of abiraterone vs enzalutamide in metastatic castration-sensitive prostate cancer (mCSPC): A propensity-matched analysis from the TriNetX Global Health Research Network.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.7_suppl.124